BALTIMORE, May 04, 2016 (GLOBE NEWSWIRE) -- WellDoc, a digital health technology leader, today announced its planned participation at several upcoming conferences and industry events in the coming months, including:
| 12th Annual Clinical Diabetes Technology Meeting | ||
| April 29 – 30, 2016, Hilton San Diego Mission Valley, San Diego, CA | ||
| WellDoc Chief Strategy Officer Anand K. Iyer, PhD, MBA, recently spoke at a plenary session entitled “Mobile Prescription Therapy: | ||
| Integrating Digital Health Tools into Mainstream Chronic Disease Management.” | ||
| For more information, visit: https://www.diabetestechnology.org/cdtm/ | ||
| NIH Precision Medicine Initiative® Cohort Program Participant Technologies Center | ||
| May 23, 2016, Embassy Suites, Washington, DC | ||
| Dr. Iyer will participate as a reviewer in the NIH Precision Medicine Initiative® Cohort Program as it relates to the White House mandated | ||
| Precision Medicine Initiative® (PMI) that enables a new era of medicine through research, technology, and policies that empower patients, | ||
| researchers, and providers to work together toward development of individualized care. | ||
| Consumer Electronic Show (CES) Digital Health Summer Summit at the Biotechnology Innovation Organization (BIO) 2016 | ||
| International Convention | ||
| June 6 – 8, 2016, Moscone Center, San Francisco, CA | ||
| WellDoc will be sharing the stage with partners, Johnson & Johnson Diabetes Care Companies and Samsung, for a plenary session/fireside | ||
| chat on June 7, 2016 at 3 p.m. PDT. | ||
| For more information, visit: https://summersummit.digitalhealthsummit.com/ | ||
| American Diabetes Association (ADA) 76th Scientific Sessions | ||
| June 10 – 14, 2016, New Orleans Ernest N. Morial Convention Center, New Orleans, LA | ||
| WellDoc Vice President of Clinical Advocacy Malinda Peeples, RN, MS, CDE, and research partners will present findings from a pilot | ||
| program on “eHealth-Assisted Lay Health Coaching for Self-Management Support.” | ||
| For more information, visit: http://professional.diabetes.org/meeting/scientific-sessions/76th-scientific-sessions | ||
| Dr. Iyer will be leading a session in the “DiabetesMine D-Data ExChange” event that connects leaders and innovators | ||
| developing diabetes data platforms and apps to make better use of health data for improved outcomes, and for reducing the burden of | ||
| those living with diabetes. | ||
| Medical Device & Manufacturing (MD&M) East 2016 Educational Conference | ||
| June 14 – 16, 2016, Jacob K. Javits Convention Center, New York, NY | ||
| A WellDoc executive will provide a keynote address on June 15, 2016, at 10:50 a.m. EDT that features a case study entitled “Mobile | ||
| Prescription Therapies – Changing the Rules of Engagement in Diabetes.” | ||
| For more information, visit: http://mdmeast.mddionline.com/ | ||
| American Association of Diabetes Educators (AADE) | ||
| August 12 – 15, 2016, San Diego Convention Center, San Diego, CA | ||
| WellDoc Director of Training, Janice MacLeod, MA, RDN, LDN, CDE will be leading a panel presentation on “Leveraging the Value of | ||
| Digital Health to Transform the Practice of the Diabetes Education.” | ||
| Ms. Peeples will participate on the panel, “Primary Care Connection: Digital Health, Peer Support, Care Coordination.” | ||
| For more information, visit: http://www.aademeeting.org/ | ||
About WellDoc®
WellDoc is a digital health technology company that develops mobile solutions to drive behavioral and clinical change in chronic disease. WellDoc’s goal is to improve patient self-management and help physicians overcome gaps in the delivery system to improve clinical outcomes and decrease cost. WellDoc has commercialized BlueStar®, a digital therapeutic, for adults with type 2 diabetes. This therapeutic is designed to fill the support gap between patients and providers during the 8700 hours that individuals live their lives outside the healthcare system each year. WellDoc has a proven track record of contributing published, peer-reviewed clinical evidence since 2008. BlueStar® is recognized by the ADA on its website as the first and only in the new class of diabetes treatment known as Mobile Prescription Therapy. In a recently published Forbes blog, WellDoc was named among one of five healthcare tech companies to watch in 2016. For more information, visit www.WellDoc.com and www.BlueStarDiabetes.com.